Author

J. I. Lee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

B. N. Kreiswirth· 1 shared D. Rifat· 1 shared E. L. Nuermberger· 1 shared J. Park· 1 shared L. Chen· 1 shared M. Jang· 1 shared N. Kurepina· 1 shared R. Park· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. N. Kreiswirth

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vitro and in vivo validation of cwlM and pbpB essentiality for viability and resistance to imipenem in Mycobacterium abscessus

E. L. Nuermberger, J. I. Lee, S.-Y. Li, D. Rifat, N. Kurepina, L. Chen, B. N. Kreiswirth

This study validates cwlM and pbpB as essential genes for Mycobacterium abscessus viability and imipenem resistance using CRISPRi in vitro and in vivo.

bioRxiv · Mar 8, 2024 · PreprintMicrobiology

Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro

M. Jang, Y.-I. Park, R. Park, Y.-E. Cha, S. Namkoong, J. I. Lee, J. Park

This study shows lopinavir and ritonavir do not inhibit SARS-CoV-2 main protease activity in vitro, suggesting they may not be effective for COVID-19 treatment.

bioRxiv · Sep 16, 2020 · PreprintMicrobiology